Private equity firm Multiples has picked up a 9.3 per cent stake in BDR Pharmaceuticals International for Rs 685 crore. The funds will be used by the company to build additional research and development (R&D) capabilities in current and emerging areas, invest in manufacturing capacity expansion and enhance the degree of vertical integration. BDR also plans to pursue inorganic expansion using the funds raised.
Multiples is the first private equity (PE) investor in BDR Pharma. "The consortium of investors participating along with Multiples include institutional investors such as the investment arm of Times Group, QRG Invest (Havells Family Office), and